Literature DB >> 6234371

Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors.

E S Dye, R J North.   

Abstract

This study was designed to investigate the specificity of the T cells that express and suppress antitumor immunity in a model of adoptive immunization against established tumors. Results obtained with the P815 mastocytoma, L5178Y lymphoma, and P388 lymphoma showed, in agreement with previous findings from this laboratory, that an intravenous infusion of splenic T cells from immunized mice can cause the regression of a tumor growing in T-cell-deficient mice. So far as specificity of adoptive immunity is concerned, reciprocal passive transfer experiments with these three tumors revealed that T cells from donor mice immunized against the P815 tumor are not capable of causing regression of the P388 tumor or L5178Y tumor, even if both the P815 and L5178Y tumors are growing in the same host. Similarly splenic T cells from mice immunized against the P388 tumor or L5178Y tumor had no effect on growth of the P815 tumor. Suppression of adoptive immunity was also specific, in that passively transferred suppressor T cells from mice bearing a progressive P815 tumor were capable of suppressing adoptive T-cell-mediated regression of the P815 tumor, but not the P388 tumor growing in T-cell-deficient recipients. Reciprocally, P388 suppressor spleen cells from mice bearing a progressive P388 tumor prevented adoptive T-cell-mediated regression of the P388 tumor, but not the P815 tumor. The results indicate, therefore, that the T cells from immunized mice that mediate adoptive antitumor immunity and the T cells from tumor-bearing mice that suppress the expression of this immunity are specific for the tumor that evokes their generation.

Entities:  

Mesh:

Year:  1984        PMID: 6234371     DOI: 10.1002/jlb.36.1.27

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

1.  Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction.

Authors:  Sayuri Yamazaki; Munjal Patel; Alice Harper; Anthony Bonito; Hidehiro Fukuyama; Maggi Pack; Kristin V Tarbell; Mia Talmor; Jeffrey V Ravetch; Kayo Inaba; Ralph M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-10       Impact factor: 11.205

Review 2.  CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

Authors:  Paul Andrew Antony; Nicholas P Restifo
Journal:  J Immunother       Date:  2005 Mar-Apr       Impact factor: 4.456

3.  Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.

Authors:  R J North
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations.

Authors:  P A Steerenberg; E Geerse; W H De Jong; R Burger; R J Scheper; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors.

Authors:  I Bursuker; R J North
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells.

Authors:  D L Hines
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppression.

Authors:  T M Tuttle; M D Fleming; P S Hogg; T H Inge; H D Bear
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

8.  Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Effect of murine interferon alpha/beta on tumour-induced suppressor function.

Authors:  D M Sahasrabudhe; J C Dusel
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

10.  T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.

Authors:  A DiGiacomo; R J North
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.